When most of us think of Alzheimer’s disease, we tend to envision a disorder that only effects a person’s neurological system. However, data is now pointing to Alzheimer’s patients experiencing a decrease in their immune system functionality as well. Doctors tested the plasma and cerebrospinal fluid of several patients, and they found significant inflammation in those prone to Alzheimer’s which could indicate potential difficulties in maintaining a strong immune system as the disease begins to progress.
- Research suggests that inflammatory markers can occur potentially decades before obvious signs of Alzheimer’s.
- New study suggests that biomarkers in the blood can show what is occurring in the brain and that the body and brain are not so separate as heretofore believed.
- Currently the sixth leading cause of death in the U.S., more than 5 million people were diagnosed with Alzheimer’s in 2017.
“Researchers have discovered that there is a link between inflammation biomarkers in both plasma and cerebrospinal fluid and markers of Alzheimer’s disease-associated pathology.”